TRIPALMITIN

TRIPALMITIN is a lipid of Glycerolipids (GL) class. Tripalmitin is associated with abnormalities such as Atherosclerosis, Hypoalphalipoproteinemias, Cystic Fibrosis, PARKINSON DISEASE, LATE-ONSET and Obesity. The involved functions are known as 5-(carboxyamino)imidazole ribonucleotide mutase activity, Certification, phosphatidylcholine-sterol O-acyltransferase activity, Regulation and Uptake. Tripalmitin often locates in Blood, Hepatic, Body tissue, Gastric mucosa and Biopsy sample. The associated genes with TRIPALMITIN are PON1 gene, very high density lipoproteins, THEMIS gene, HEPATIC PROTEIN and chylomicron remnant. The related lipids are Fatty Acids, Total cholesterol, Nonesterified Fatty Acids, Palmitates and tristearin.

Cross Reference

Introduction

To understand associated biological information of TRIPALMITIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with TRIPALMITIN?

TRIPALMITIN is suspected in Atherosclerosis, Fatty Liver, Cystic Fibrosis, Hypoalphalipoproteinemias, PARKINSON DISEASE, LATE-ONSET, Obesity and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with TRIPALMITIN

MeSH term MeSH ID Detail
Leishmaniasis, Visceral D007898 13 associated lipids
Respiratory Distress Syndrome, Newborn D012127 5 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Malabsorption Syndromes D008286 16 associated lipids
HIV-Associated Lipodystrophy Syndrome D039682 3 associated lipids
Total 5

PubChem Associated disorders and diseases

What pathways are associated with TRIPALMITIN

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with TRIPALMITIN?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with TRIPALMITIN?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with TRIPALMITIN?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with TRIPALMITIN?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with TRIPALMITIN?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with TRIPALMITIN

Download all related citations
Per page 10 20 50 100 | Total 272
Authors Title Published Journal PubMed Link
Antony P et al. Micro-scale flow cytometry-based and biochemical analysis of lipid signaling in primary B cell subpopulations. 2007 Biol Proced Online pmid:18385809
Uner M and Yener G Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. 2007 Int J Nanomedicine pmid:18019829
Hazotte A et al. High-temperature micro liquid chromatography for lipid molecular species analysis with evaporative light scattering detection. 2007 J Chromatogr A pmid:17161844
Chattopadhyay P et al. Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system. 2007 Adv. Drug Deliv. Rev. pmid:17582648
Kumar VV et al. Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics. 2007 Int J Pharm pmid:17161566
Diakogiannaki E et al. Mechanisms involved in the cytotoxic and cytoprotective actions of saturated versus monounsaturated long-chain fatty acids in pancreatic beta-cells. 2007 J. Endocrinol. pmid:17641278
Karupaiah T and Sundram K Effects of stereospecific positioning of fatty acids in triacylglycerol structures in native and randomized fats: a review of their nutritional implications. 2007 Nutr Metab (Lond) pmid:17625019
Maduko CO et al. Enzymatic interesterification of tripalmitin with vegetable oil blends for formulation of caprine milk infant formula analogs. 2007 J. Dairy Sci. pmid:17235135
Hitzman CJ et al. Development of a respirable, sustained release microcarrier for 5-fluorouracil II: In vitro and in vivo optimization of lipid coated nanoparticles. 2006 J Pharm Sci pmid:16570303
Tosi A et al. Tripalmitin-based cationic lipospheres: preparation, characterization and in Lab-on-a-chip applications. 2006 J Control Release pmid:17718971
Appel B et al. Lipidic implants for controlled release of bioactive insulin: effects on cartilage engineered in vitro. 2006 Int J Pharm pmid:16569486
Elkharraz K et al. Paclitaxel-loaded microparticles and implants for the treatment of brain cancer: preparation and physicochemical characterization. 2006 Int J Pharm pmid:16490330
Koennings S et al. In vitro investigation of lipid implants as a controlled release system for interleukin-18. 2006 Int J Pharm pmid:16513302
Guse C et al. Biocompatibility and erosion behavior of implants made of triglycerides and blends with cholesterol and phospholipids. 2006 Int J Pharm pmid:16517106
Srivastava A et al. Candida rugosa lipase LIP1-catalyzed transesterification to produce human milk fat substitute. 2006 J. Agric. Food Chem. pmid:16819932
Manjunath K and Venkateswarlu V Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration. 2006 J Drug Target pmid:17090399
Ciafardini G et al. Lipase production by yeasts from extra virgin olive oil. 2006 Food Microbiol. pmid:16942987
Reddy LH et al. Tamoxifen citrate loaded solid lipid nanoparticles (SLN): preparation, characterization, in vitro drug release, and pharmacokinetic evaluation. 2006 Pharm Dev Technol pmid:16749527
Tursilli R et al. Enhancement of melatonin photostability by encapsulation in lipospheres. 2006 J Pharm Biomed Anal pmid:16242283
Moffitt JH et al. Adverse physicochemical properties of tripalmitin in beta cells lead to morphological changes and lipotoxicity in vitro. 2005 Diabetologia pmid:16094531